Updated Jul 16, 2026
Duey Marc has filed 1 SEC Form 4 filing across 1 company in the last 90 days — active on both sides. Lifetime open-market purchases: $132K. Lifetime open-market sales: $30K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-17 | APRE | Aprea Therapeutics, Inc. | A — Grant or award | 3.1K | $0.00 | |
| 2024-10-25 | APRE | Aprea Therapeutics, Inc. | S — Open-market sale | 6.5K | $4.58 | $30K |
| 2024-10-17 | APRE | Aprea Therapeutics, Inc. | P — Open-market purchase | 30.0K | $4.39 | $132K |
| 2024-10-16 | APRE | Aprea Therapeutics, Inc. | P — Open-market purchase | 190 | $2.58 | $490 |
Duey Marc is a corporate insider — currently tracked as Director of Aprea Therapeutics, Inc. (APRE). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($132K) and 1 open-market sales ($30K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Duey Marc profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.